ORMP Stock Forecast- Quick Win: 23.33% Return
ORMP Stock Forecast
Oramed Pharmaceuticals Inc. (Oramed) is engaged in the field of oral delivery solutions for drugs and vaccines presently delivered via injection.The company was given a strongly bullish 3 day rating by the I Know First stock-trading algorithm, on November 27th. Amazingly 3 days after the stock rose by a whopping 23.33%.
In a press-release today, Oramed Pharmaceuticals, Inc. announced that it has signed definitive licensing and investment agreements with Hefei Tianhui Incubator of Technologies (HTIT), for exclusive rights to market ORMD-0801 in China. The agreements, which are valued up to $50 million, were signed at the Israeli Knesset.
Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First algorithmic traders.
